Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole for laryngopharyngeal reflux symptom improvement by BMI
KCT0004035Phase 4Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ilaprazole in laryngopharyngeal reflux (LPR), sponsored by Il-Yang Pharmaceutical. Primary endpoint: Improvement in main symptoms of laryngopharyngeal reflux disease. Started Jul 2019; status: completed.
02
Drugs
ilaprazole
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on KCT0004035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004035.